However, chronic or excessive hyperosmolar conditions, whether localized (e.g., in the kidneys, central nervous system, or eye) or systemic (such as in diabetes), can push NFAT5 regulatory capacity into a pathological state. Here, NFAT5 is linked to diabetes mellitus.